Your browser doesn't support javascript.
loading
Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3- ITD mutations: results of the SAL MIDOKIT trial.
Ruhnke, Leo; Röllig, Christoph; Herold, Sylvia; Sauer, Tim; Brandts, Christian H; Steffen, Björn; Schäfer-Eckart, Kerstin; Krause, Stefan W; Hänel, Mathias; Reichle, Albrecht; Scholl, Sebastian; Neubauer, Andreas; Mikesch, Jan-Henrik; Schetelig, Johannes; Stölzel, Friedrich; Kramer, Michael; Haake, Annett; Frimmel, Julia; Krämer, Alwin; Schlenk, Richard; Platzbecker, Uwe; Serve, Hubert; Baldus, Claudia D; Müller-Tidow, Carsten; Aust, Daniela; Bornhäuser, Martin; Ehninger, Gerhard; Thiede, Christian.
Afiliação
  • Ruhnke L; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden. leo.ruhnke@ukdd.de.
  • Röllig C; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden.
  • Herold S; Institute of Pathology, University Hospital Dresden, Dresden.
  • Sauer T; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany; German Cancer Consortium (DKTK) partner site Dresden, Dresden, Germany and German Cancer Research Center (DKFZ), Heidelberg.
  • Brandts CH; Department of Internal Medicine II, University Hospital Frankfurt, Frankfurt.
  • Steffen B; Department of Internal Medicine II, University Hospital Frankfurt, Frankfurt.
  • Schäfer-Eckart K; Department of Internal Medicine V, Nuremberg Hospital North, Paracelsus Medical University, Nuremberg.
  • Krause SW; Department of Internal Medicine V, University Hospital Erlangen, Erlangen.
  • Hänel M; Department of Internal Medicine III, Chemnitz Hospital, Chemnitz.
  • Reichle A; Department of Internal Medicine III, Hematology and Internal Oncology, University Hospital Regensburg, Regensburg.
  • Scholl S; Department of Internal Medicine II, Hematology and Internal Oncology, University Hospital Jena, Jena.
  • Neubauer A; Department of Internal Medicine, Hematology, Oncology and Immunology, University Hospital Marburg, Marburg.
  • Mikesch JH; Department of Internal Medicine A, University Hospital Münster, Münster.
  • Schetelig J; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany; DKMS Clinical Trials Unit, Dresden.
  • Stölzel F; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden.
  • Kramer M; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden.
  • Haake A; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden.
  • Frimmel J; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden.
  • Krämer A; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany; German Cancer Consortium (DKTK) partner site Dresden, Dresden, Germany and German Cancer Research Center (DKFZ), Heidelberg.
  • Schlenk R; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany; German Cancer Consortium (DKTK) partner site Dresden, Dresden, Germany and German Cancer Research Center (DKFZ), Heidelberg.
  • Platzbecker U; Department of Internal Medicine I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig.
  • Serve H; Department of Internal Medicine II, University Hospital Frankfurt, Frankfurt.
  • Baldus CD; Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel.
  • Müller-Tidow C; Department of Internal Medicine V, University of Heidelberg, Heidelberg.
  • Aust D; Institute of Pathology, University Hospital Dresden, Dresden.
  • Bornhäuser M; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany; German Cancer Consortium (DKTK) partner site Dresden, Dresden, Germany and German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT) Dresden, Dresden.
  • Ehninger G; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden.
  • Thiede C; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany; Agendix GmbH, Dresden.
Haematologica ; 108(9): 2520-2525, 2023 09 01.
Article em En | MEDLINE | ID: mdl-36779591
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2023 Tipo de documento: Article